FDA Investigator

Terri E Gibson

Latest inspection on record: Houston, United States, June 2026 · records back to 2022

Medical Devices & Rad HealthHuman DrugsBiologics

FDA inspection record · Last updated August 15, 2026

Overview

  • 49 inspections across 48 sites are on record.
  • 119 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-19.

At a glance

Inspections

49

Sites

48

Observations

119

Career since

Feb 2022

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Moran Amit, M.D., Ph.D.19 Jun 2026Human Drugs
Bhasker R. Mehta, M.D.2 Jun 2026Human DrugsView 483 →
Osteal Therapeutics Inc7 May 2026Human Drugs
Prithviraj Bose, M.D.30 Apr 2026Human DrugsView 483 →
University of Texas at Arlington IRB17 Apr 2026Medical Devices & Rad Health

Sites inspected

Moran Amit, M.D., Ph.D.Houston, United States1 insp.
Bhasker R. Mehta, M.D.Arlington, United States1 insp.
Osteal Therapeutics IncDallas, United States1 insp.
Prithviraj Bose, M.D.Houston, United States1 insp.
University of Texas at Arlington IRBArlington, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Terri E Gibson's 119 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site